Drug Profile
TAK 680
Alternative Names: SHP 680; TAK-680Latest Information Update: 18 Jul 2019
Price :
$50
*
At a glance
- Originator Shire
- Developer Takeda
- Class Amphetamines; Nootropics; Small molecules
- Mechanism of Action Adrenergic receptor agonists; Central nervous system stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cognition disorders